등록된 논문 166건

※ 클릭시 해당 논문페이지로 이동합니다.

• KCSG UN18-06희귀암

  Phase 2 trial of avelumab in combination with gemcitabine in advanced leiomyosarcoma as a second-line treatment (EAGLES, Korean Cancer Study Group UN18-06)

  • 저널 Cancer. 2025 Jan 1;131(1):e35609.
  • 제1저자 김미소, 김유정
  • 교신저자 김영생, 안진희

• KCSG BR18-16유방암

  Genomic and transcriptomic profiles associated with response to eribulin and nivolumab combination in HER?2?negative metastatic breast cancer

  • 저널 Cancer Immunol Immunother . 2024 Aug 6;73(10):197.
  • 제1저자 박창희, 서경진
  • 교신저자 김세현

• KCSG GU23-08비뇨기암

  Four versus six cycles of platinum-based chemotherapy for advanced Urothelial carcinoma in the era of immune checkpoint inhibitors: A retrospective cohort study (FOCUS, KCSG-GU23-08)

  • 저널 Curr Probl Cancer. 2024 Sep 22:53:101149.
  • 제1저자 박권오
  • 교신저자 이재련

• KCSG AL19-17기타

  A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17)

  • 저널 ESMO Open. 2024 Sep;9(9):103668.
  • 제1저자 강은주, 양예은
  • 교신저자 이기형

• KCSG LU20-15폐암

  Lazertinib in EGFR-Variant Non-Small Cell Lung Cancer With CNS Failure to Prior EGFR Tyrosine Kinase Inhibitors: A Nonrandomized Controlled Trial

  • 저널 JAMA Oncol. 2024 Aug 15:e242640.
  • 제1저자 홍민희, 최윤지, 안희경
  • 교신저자 김혜련, 강진형

• KCSG LU17-19폐암

  A phase II study of osimertinib in patients with NSCLC harboring EGFR exon 20 insertion: A multicenter trial of the Korean Cancer Study Group

  • 저널 Lung Cancer. 2024 Aug:194:107870.
  • 제1저자 김유정, 김소연
  • 교신저자 김태민

• KCSG BR19-15유방암

  A nationwide real-world study for evaluation of effectiveness and safety of T-DM1 in patients with HER2-positive metastatic breast cancer in Korea (KCSG BR19-15)

  • 저널 Ther Adv Med Oncol 2024, Vol. 16: 1-15
  • 제1저자 백선경, 정재호
  • 교신저자 이경은, 박연희

• KCSG HN18-17두경부식도암

  A phase 2 study of spartalizumab (PDR001) among patients with recurrent or metastatic esophageal squamous cell carcinoma (KCSG HN18-17, K-MASTER project 12)

  • 저널 Oncoimmunology . 2024 Jun 24;13(1):2371563.
  • 제1저자 이동기
  • 교신저자 홍민희

• NANA

  The Survival and Financial Benefit of Investigator-Initiated Trials Conducted by Korean Cancer Study Group

  • 저널 Cancer Res Treat . 2024 Jul 10. doi: 10.4143/crt.2024.421. Online ahead of print
  • 제1저자 김범준
  • 교신저자 장대영

• KCSG AL22-09기타

  Pragmatic nationwide master observational trial based on genomic alterations in advanced solid tumors: KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS)-II study protocol KCSG AL-22-09

  • 저널 BMC Cancer . 2024 May 9;24(1):574
  • 제1저자 김선영
  • 교신저자 김지현

12345